Related Experiment Video
Updated: Feb 4, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
[Clinical and demographic features of patients with stroke and atrial fibrillation]
D M Akpanova1, S F Berkinbayev1, A T Mussagaliyeva1
1Scientific and Research Institute of Cardiology and Internal Diseases, Almaty.
Insights
Atrial fibrillation (AF) affects over 10% of stroke patients, significantly increasing in-hospital mortality risk. Few AF patients received preventive therapy, highlighting a critical gap in stroke prevention strategies.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Stroke is a leading cause of death and disability globally.
- Atrial fibrillation (AF) is a major independent risk factor for ischemic stroke.
- Stroke prevention remains a significant medical and societal challenge.
Purpose of the Study:
- To determine the prevalence of atrial fibrillation (AF) in patients hospitalized with stroke or transient ischemic attack (TIA).
- To assess the use of anticoagulant therapy in AF patients with stroke/TIA prior to hospitalization.
- To evaluate the in-hospital mortality rates associated with AF in stroke/TIA patients.
Main Methods:
- Retrospective analysis of 7,921 patient case reports from January 2013 to December 2015.
- Selection of 849 case reports for patients diagnosed with both acute cerebrovascular disease/TIA and AF.
- Utilized CHA2DS2‑VASc scale for risk stratification and analyzed mortality data.
Main Results:
- The incidence of AF among stroke/TIA patients was 10.72%.
- A high percentage (93.8%) of AF patients were classified as high-risk for thromboembolic complications.
- Only 4.7% of AF patients received preventive therapy.
- In-hospital mortality was significantly higher in patients with AF (15.78%) compared to those without AF (7.01%).
Conclusions:
- Atrial fibrillation is a significant risk factor for in-hospital mortality in stroke/TIA patients.
- There is a substantial gap in the preventive therapy uptake for thromboembolic complications in AF patients with stroke/TIA.
- Improved screening and management of AF in stroke patients are crucial for reducing mortality.
Background:
Stroke takes the second place among all causes for cardiovascular death and the first place in mortality and disability among other nervous system diseases. Atrial fibrillation (AF) is presently is a commonly recognized, independent risk factor for ischemic stroke, which fivefold increases the risk of an unfavorable outcome. Prevention of stroke is a complicated medical and social challenge.
Aim:
To study AF prevalence among patients with stroke/transient ischemic attack (TIA) who had received an anticoagulant therapy before hospitalization.
Materials And Methods:
A retrospective analysis of case reports was performed for patients diagnosed with acute cerebrovascular disease and TIA who had received a therapy from January, 2013 through December, 2015 (n=7921). From these case reports, 849 case reports of patients with concurrent AF were selected.
Results:
In patients with stroke/TIA, the AF incidence was 10.72%. Risk assessment using the CHA2DS2‑VASc scale showed that the percentage of low-risk patients (score 0) was 0.8%, intermediate risk patients (score 1) - 5.3%, and high-risk patients (score ≥2) - 93.8%; 4.7% of patients with AF received preventive therapy for thromboembolic complications. The death rate of patients with AF and stroke/TIA was 15.78% whereas in-hospital death rate of patients without AF was 7.01%. Therefore, AF is a statistically significant risk factor of in-hospital mortality for patients with stroke/TIA (OR=2.485; 95% CI: 2.023-3.053; p.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

